Gentler chemo approach offers hope for elderly cancer patients often left behind

This study is testing a new way to give standard chemotherapy (R-CHOP) to older adults with an aggressive type of lymphoma called DLBCL. The goal is to split the doses over two weeks instead of giving them all at once, which researchers hope will be easier for older patients to tolerate while still effectively fighting the cancer. The study focuses on patients aged 75 and older, a group often excluded from clinical trials, and will monitor if this approach can successfully control the disease with fewer side effects.